Julian Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julian Wong has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Gillian Pearce
Department of Mechatronics and Biomedical Engineering, College of Engineering and Physical Sciences, Aston University, Birmingham, UK
2 shared publications - Oguz Akin
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
2 shared publications - Perihan Unak
Ege University, Institute of Nuclear Sciences, Department of Nuclear Applications, Bornova Izmir, 35100, Turkey
2 shared publications - Steven Thomas Russell
Aston University, School of Life and Health Sciences, Aston Triangle, Birmingham, B4 7ET, United Kingdom
2 shared publications - Tjun Yip Tang
The Vascular & Endovascular Clinic, Gleneagles Medical Centre, Singapore, Singapore
2 shared publications - Volkan Yasakci
Ege University, Institute of Nuclear Sciences, Department of Nuclear Applications, Bornova Izmir, 35100, Turkey
2 shared publications
Latest Publications
- Open Access
- 23 August 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 04145
Foot care behaviours and associated factors among patients with type 2 diabetes: A cross-sectional study
Type 2 diabetes mellitus (T2DM) is a highly prevalent chronic disease and the ninth leading cause of mortality worldwide [1]. An estimated 529 million people had diabetes in 2021, with T2DM accounting for approximately 96% of all diabetes cases globally [2]. The prevalence of T2DM is particularly pronounced in Asia, with 60% of people with […]
- 23 August 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 04145
Open AccessFoot care behaviours and associated factors among patients with type 2 diabetes: A cross-sectional study
Type 2 diabetes mellitus (T2DM) is a highly prevalent chronic disease and the ninth leading cause of mortality worldwide [1]. An estimated 529 million people had diabetes in 2021, with T2DM accounting for approximately 96% of all diabetes cases globally [2]. The prevalence of T2DM is particularly pronounced in Asia, with 60% of people with […]
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , E35
More Food for Thought for Use of Paclitaxel in the Below-the-Knee Arena in the Setting of Critical Limb Ischemia
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , E35
More Food for Thought for Use of Paclitaxel in the Below-the-Knee Arena in the Setting of Critical Limb Ischemia
- 27 May 2021
- Published by International Society of Communication and Development Between Universities (ISCDBU)
- Vol. 4 (3) , 229-239
Toxicity testing of indocyanine green and fluorodeoxyglucose conjugated iron oxide nanoparticles with and without exposure to a magnetic field
Iron nanoparticles (MNPs) are known to induce membrane damage and apoptosis of cancer cells. In our study we determined whether FDG coupled with iron oxide magnetic nanoparticles can exert the same destructive effect on cancer cells. This research study presents data involving NIC-H727 human lung, bronchus epithelial cells exposed to conjugated fluorodeoxyglucose conjugated with iron-oxide magnetic nanoparticles and indocyanine green (ICG) dye (FDG-MNP-ICG), with and without the application of a magnetic field. Cell viability inferred from MTT assay revealed that FDG-MNPs had no significant toxicity towards noncancerous NIC-H727 human lung, bronchus epithelial cells. However, percentage cell death was much higher using a magnetic field, for the concentration of FDG-MNP-ICC used in our experiments. Magnetic field was able to destroy cells containing MNPs, while MNPs alone had significantly lower effects. Additionally, MNPs alone in these low concentrations had less adverse effects on healthy (non-target) cells.
- 27 May 2021
- Published by International Society of Communication and Development Between Universities (ISCDBU)
- Vol. 4 (3) , 229-239
Toxicity testing of indocyanine green and fluorodeoxyglucose conjugated iron oxide nanoparticles with and without exposure to a magnetic field
Iron nanoparticles (MNPs) are known to induce membrane damage and apoptosis of cancer cells. In our study we determined whether FDG coupled with iron oxide magnetic nanoparticles can exert the same destructive effect on cancer cells. This research study presents data involving NIC-H727 human lung, bronchus epithelial cells exposed to conjugated fluorodeoxyglucose conjugated with iron-oxide magnetic nanoparticles and indocyanine green (ICG) dye (FDG-MNP-ICG), with and without the application of a magnetic field. Cell viability inferred from MTT assay revealed that FDG-MNPs had no significant toxicity towards noncancerous NIC-H727 human lung, bronchus epithelial cells. However, percentage cell death was much higher using a magnetic field, for the concentration of FDG-MNP-ICC used in our experiments. Magnetic field was able to destroy cells containing MNPs, while MNPs alone had significantly lower effects. Additionally, MNPs alone in these low concentrations had less adverse effects on healthy (non-target) cells.
- 19 December 2020
- Published by International Society of Communication and Development Between Universities (ISCDBU)
- Vol. 4 (1) , 53-66
Effects of fluorodeoxyglucose magnetic nanoparticles on NCI-H727 and SH-SY5Y cancer cells
We present a report regarding the cytotoxic effects of iron-based magnetic nanoparticles conjugated with fluorodeoxyglucose (FDG-mNPs) on the viability of NCI-H727 and SH-SY5Y cancer cells. MTT assays were performed to determine cell viability in treated cancer cells grown under standard 2D culture conditions. FDG-mNP concentrations of 0.075 mg/mL, 0.15 mg/mL, and 0.3 mg/mL decreased mean cell viability of NCI-H727 cells to 92.5%, 82.9%, and 75% respectively. FDG-mNPs was also shown to have a detrimental effect on the viability of SY5Y cells: a decrease of 5.7%, 18.6%, and 36.4% was found for SY5Y cells treated with 0.075 mg/mL, 0.15 mg/mL, and 0.3 mg/mL concentrations of FDG-mNPs, respectively. When NCI-H727 and SH-SY5Y cancer cells were grown as 3D spheroids, morphology was visibly changed and the number of viable cells was decerased in spheroids treated with FDG-mNPs compared with untreated spheroids. The results of our study demonstrated that FDG-mNP has toxic effects on NCI-H7272 and SY5Y cancer cells, and we conclude that conjugated FDG-mNPs are promising in the development of clinical applications for the destruction of cancer cells.
- 19 December 2020
- Published by International Society of Communication and Development Between Universities (ISCDBU)
- Vol. 4 (1) , 53-66
Effects of fluorodeoxyglucose magnetic nanoparticles on NCI-H727 and SH-SY5Y cancer cells
We present a report regarding the cytotoxic effects of iron-based magnetic nanoparticles conjugated with fluorodeoxyglucose (FDG-mNPs) on the viability of NCI-H727 and SH-SY5Y cancer cells. MTT assays were performed to determine cell viability in treated cancer cells grown under standard 2D culture conditions. FDG-mNP concentrations of 0.075 mg/mL, 0.15 mg/mL, and 0.3 mg/mL decreased mean cell viability of NCI-H727 cells to 92.5%, 82.9%, and 75% respectively. FDG-mNPs was also shown to have a detrimental effect on the viability of SY5Y cells: a decrease of 5.7%, 18.6%, and 36.4% was found for SY5Y cells treated with 0.075 mg/mL, 0.15 mg/mL, and 0.3 mg/mL concentrations of FDG-mNPs, respectively. When NCI-H727 and SH-SY5Y cancer cells were grown as 3D spheroids, morphology was visibly changed and the number of viable cells was decerased in spheroids treated with FDG-mNPs compared with untreated spheroids. The results of our study demonstrated that FDG-mNP has toxic effects on NCI-H7272 and SY5Y cancer cells, and we conclude that conjugated FDG-mNPs are promising in the development of clinical applications for the destruction of cancer cells.
- 1 September 2020
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 72 (3) , 1145
Analysis of Midterm Outcomes of Endovascular Aneurysm Repair in Octogenarians From the ENGAGE Registry
- 1 September 2020
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 72 (3) , 1145
Analysis of Midterm Outcomes of Endovascular Aneurysm Repair in Octogenarians From the ENGAGE Registry
- 1 September 2019
- Published by Elsevier in Journal of Biomechanics
- Vol. 94, 193-201
Numerical modelling of blood clot extraction by aspiration thrombectomy. Evaluation of aspiration catheter geometry
- 1 September 2019
- Published by Elsevier in Journal of Biomechanics
- Vol. 94, 193-201
Numerical modelling of blood clot extraction by aspiration thrombectomy. Evaluation of aspiration catheter geometry